Verified earnings results
Atrium Therapeutics Q3 2026 Earnings Results
Direct answer
Atrium Therapeutics reported Q3 2026 results on November 12, 2026.
Revenue was 15,321,000. EPS beat the estimate by 69.44%.
The result is verified against Verified earnings source.
Verified earnings source
Get free Atrium Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- November 12, 2026
- Reported timing
- After the US market closes
- EPS estimate
- -0.8181
- Reported EPS
- -0.25
- Revenue
- 15,321,000
- EPS surprise
- EPS beat the estimate by 69.44%.
Explore related company data
Read the frequently asked questions.
When did Atrium Therapeutics report Q3 2026 earnings?
Atrium Therapeutics reported on November 12, 2026. The reported timing was after the us market closes.
What is the available EPS estimate for Atrium Therapeutics?
The verified record provides an EPS estimate of -0.8181.
Has Atrium Therapeutics reported the Q3 2026 result?
Revenue was 15,321,000. EPS beat the estimate by 69.44%.
Which source supports this Atrium Therapeutics earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.